Ibuprofen Catalent (Ibuprofen)

Ibuprofen works by non‑selectively inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. Lower prostaglandin levels reduce pain signaling, fever response, and inflammatory swelling.

The appropriate dose of Ibuprofen Catalent is determined by a qualified prescriber based on the patient’s age, weight, condition, and clinical response. Healthcare professionals set the strength, frequency, and duration of therapy according to current medical guidelines.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. Generally, ibuprofen is avoided in the third trimester and used with caution earlier. Breastfeeding mothers should consult a healthcare provider before use.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibuprofen shares the same COX‑inhibiting mechanism as other NSAIDs such as naproxen and diclofenac, but it has a relatively short half‑life and is often chosen for its well‑documented safety profile at recommended doses. Choice depends on patient tolerance, dosing convenience, and specific clinical needs.

Ibuprofen Catalent should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain its stability and potency.

The medication is taken orally, usually with a full glass of water. It can be swallowed with or without food, although taking it with meals or milk may lessen gastrointestinal discomfort.

Serious risks include gastrointestinal bleeding or ulceration, renal impairment, severe allergic reactions such as anaphylaxis, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, rash, or breathing difficulties.

Individuals with a known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment should avoid using Ibuprofen Catalent unless directed by a physician.